Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Related Collections
Right arrow All Neuromuscular Disease
Right arrow Anterior nerve cell disease
Right arrow Amyotrophic lateral sclerosis
Right arrow All epidemiology
Right arrow Incidence studies
Neurology 2001;56:239-244
© 2001 American Academy of Neurology


Articles

Incidence of ALS in Italy

Evidence for a uniform frequency in Western countries

Piemonte and Valle d’Aosta Register for Amyotrophic Lateral Sclerosis (PARALS)*

From the Piemonte and Valle d’Aosta Register for Amyotrophic Lateral Sclerosis (PARALS).

Address correspondence and reprint requests to Dr. Adriano Chiò, Department of Neuroscience, Via Cherasco 15, 10126 Torino, Italy; e-mail: achio{at}usa.net

OBJECTIVE: To determine the incidence of ALS in two regions of Northwestern Italy, utilizing a prospective design.

METHODS: The study was performed in Piemonte and Valle d’Aosta (4,418,503 inhabitants) during the period 1995 to 1996. All neurologic departments in the two regions were involved in the study and prospectively collected and followed up ALS cases. Other secondary sources of information were used in order to ensure complete case ascertainment. ALS diagnosis was based on El Escorial criteria. Although all patients with motor neuron disease were enrolled in the follow-up, only probable and definite cases are included in the study.

RESULTS: During the study period, 221 cases of ALS were found (120 men and 101 women), corresponding to a mean annual crude incidence rate of 2.5/100,000 population (95% CI 2.2 to 2.9). The rate was higher for men (2.9) than for women (2.3), and increased with age to a peak in the 75 to 79 age group among men and to the 70 to 74 age group among women.

CONCLUSIONS: Comparing these data to those of epidemiologic studies with a similar prospective design, the incidence rates are similar, despite the large differences in terms of genetics, environment, and socioeconomic background. This finding points to diffuse environmental or genetic factors rather than to a specific exogenous toxin in the pathogenesis of ALS.




This article has been cited by other articles:


Home page
NeurologyHome page
A. Chio, G. Mora, A. Calvo, L. Mazzini, E. Bottacchi, R. Mutani, and On behalf of the PARALS
Epidemiology of ALS in Italy: A 10-year prospective population-based study
Neurology, February 24, 2009; 72(8): 725 - 731.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Murphy, S. Quinn, J. Young, P. Parkin, and B. Taylor
Increasing incidence of ALS in Canterbury, New Zealand: A 22-year study
Neurology, December 2, 2008; 71(23): 1889 - 1895.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Sabatelli, F. Madia, A. Conte, M. Luigetti, M. Zollino, I. Mancuso, M. Lo Monaco, G. Lippi, and P. Tonali
Natural history of young-adult amyotrophic lateral sclerosis
Neurology, September 16, 2008; 71(12): 876 - 881.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. Gkogkas, S. Middleton, A. M. Kremer, C. Wardrope, M. Hannah, T. H. Gillingwater, and P. Skehel
VAPB interacts with and modulates the activity of ATF6
Hum. Mol. Genet., June 1, 2008; 17(11): 1517 - 1526.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Chio, B. J. Traynor, F. Lombardo, M. Fimognari, A. Calvo, P. Ghiglione, R. Mutani, and G. Restagno
Prevalence of SOD1 mutations in the Italian ALS population
Neurology, February 12, 2008; 70(7): 533 - 537.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G Logroscino, B J Traynor, O Hardiman, A Chio', P Couratier, J D Mitchell, R J Swingler, E Beghi, and for EURALS
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 6 - 11.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J.C. Schymick, K. Talbot, and B.J. Traynor
Genetics of sporadic amyotrophic lateral sclerosis
Hum. Mol. Genet., October 15, 2007; 16(R2): R233 - R242.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Cronin, O. Hardiman, and B. J. Traynor
Ethnic variation in the incidence of ALS: A systematic review
Neurology, March 27, 2007; 68(13): 1002 - 1007.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Hirtz, D. J. Thurman, K. Gwinn-Hardy, M. Mohamed, A. R. Chaudhuri, and R. Zalutsky
How common are the "common" neurologic disorders?
Neurology, January 30, 2007; 68(5): 326 - 337.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. Beghi, A. Millul, A. Micheli, E. Vitelli, G. Logroscino, and for the SLALOM Group
Incidence of ALS in Lombardy, Italy
Neurology, January 9, 2007; 68(2): 141 - 145.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Chio, E Bottacchi, C Buffa, R Mutani, G Mora, and the PARALS
Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities
J. Neurol. Neurosurg. Psychiatry, August 1, 2006; 77(8): 948 - 950.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Mandrioli, P. Faglioni, E. Merelli, and P. Sola
The epidemiology of ALS in Modena, Italy
Neurology, February 25, 2003; 60(4): 683 - 689.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
K Talbot
Motor neurone disease
Postgrad. Med. J., September 1, 2002; 78(923): 513 - 519.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Chio, G. Mora, M. Leone, L. Mazzini, D. Cocito, M. T. Giordana, E. Bottacchi, and R. Mutani
Early symptom progression rate is related to ALS outcome: A prospective population-based study
Neurology, July 9, 2002; 59(1): 99 - 103.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.